Jun 18, 2024
Industry and Company News Second Quarter 2024
The second quarter 2024 issue includes announcements about a member dividend and the appointment of our new chief operating officer.
From
The Doctor’s Advocate
Search
Professional Education
Module 3: Safe Prescribing of Opioids and CNS Depressants (Innovations and Smart Approaches in Safe Prescribing)
Learn several new concepts and innovation tips. Learn about the new CDC Guidelines about pain. This program will show how to treat pain, opioid withdrawal, and/or opioid addiction. It will show how to taper opioids and you will learn how to conduct “motivational interviewing.” You will examine multimodal approaches for chronic pain, including physical, psych-behavioral, procedural, and pharmacological modalities. You will be encouraged to use tools for prescribing and tapering opioids and benzodiazepines. You will be provided with an overview of the use of CURES 2.0. Lastly, the program will examine how to best screen patients for use of CNS depressants and marijuana to mitigate the potential for contraindications with opioids. This module consists of seven audio-filled videos. To successfully complete this course, you need to achieve a passing score of 80 percent in the post-test questions.
Close the Loop on Test Results
Confirming a colleague’s receipt and understanding of serious findings is part of patient safety. Further, closed-loop communication expresses mutual respect, which contributes to professional satisfaction.
Perioperative Claims for General Surgeons
About 63 percent of general surgeons have been involved in a medical malpractice suit. Understanding the most common types of complications and the factors that contribute to errors may provide insights for general surgeons about their practice.
Professional Education
The Alzheimer’s Project CME Series
Because of an inadequate number of neurologists, psychiatrists, and geriatricians serving an increasing population of seniors with cognitive decline, most dementias will be diagnosed and managed by primary care practitioners. The Alzheimer’s Project is an on-demand CME series that trains primary care physicians and other healthcare practitioners on standardized screening, evaluation, and management of Alzheimer’s disease and related dementias.
CMA Exclusive Corporate Sponsor
The California Medical Association (CMA), representing nearly 50,000 physicians, has chosen The Doctors Company, part of TDC Group, as its exclusive medical professional liability insurance company (MPLI) corporate sponsor.
AI, COVID-19, and Future Pandemics
Artificial intelligence (AI) has proven of value in the COVID-19 pandemic and shows promise for mitigating future healthcare crises.
Jun 05, 2025
The Doctors Company Announces Acquisition of ProAssurance
The Doctors Company has entered into a definitive agreement to acquire ProAssurance, and other company news and insights.
From
The Doctor’s Advocate
April 03, 2025, Cardiology Magazine
Critical Insights: Lessons From Delayed Diagnosis, Treatment in the ED
John P. Erwin III, MD, MBA, MACC, Chair, Department of Internal Medicine, Prisma Health Upstate; Clinical Professor, School of Medicine Greenville, University of South Carolina; and Debra A. Davidson, MJ, CPHRM, CPPS, Senior Patient Safety Risk Manager, The Doctors Company, part of TDC Group, review how care and treatment delays contribute to poor patient outcomes and medical malpractice litigation.
Nuclear Verdicts Increase Healthcare Costs
Social inflation increases the price of healthcare. It ratchets up the costs of doing business for healthcare professionals and facilities, and fear of litigation inspires defensive medicine. Fortunately, through tort reform, states may be able to contain social inflation’s effects on healthcare costs.